[Ranibizumab as a treatment for type 2 non-proliferative macular telangiectasia].
Troumani Y, M'garrech M, Touhami S, Hayek S, Barreau E, Bonin L, Rousseau A, Labetoulle M.
Troumani Y, et al. Among authors: labetoulle m, m garrech m.
J Fr Ophtalmol. 2016 Jan;39(1):e9-e11. doi: 10.1016/j.jfo.2014.08.016. Epub 2015 Nov 12.
J Fr Ophtalmol. 2016.
PMID: 26584774
French.
No abstract available.